Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/59339
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMasahiko Isakaen_US
dc.contributor.authorUrarat Srisanohen_US
dc.contributor.authorSukitaya Veeranondhaen_US
dc.contributor.authorWilunda Choowongen_US
dc.contributor.authorSaisamorn Lumyongen_US
dc.date.accessioned2018-09-10T03:14:02Z-
dc.date.available2018-09-10T03:14:02Z-
dc.date.issued2009-10-24en_US
dc.identifier.issn00404020en_US
dc.identifier.other2-s2.0-70349220966en_US
dc.identifier.other10.1016/j.tet.2009.08.077en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70349220966&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/59339-
dc.description.abstractBerkleasmins A-E, five new eremophilane sesquiterpenoids were isolated from the saprobic fungus Berkleasmium nigroapicale BCC 8220. The structures of the new compounds were elucidated by analyses of NMR spectroscopic and mass spectrometry data in combination with chemical means. Berkleasmins A and C exhibited cytotoxic activity against cancer cell-lines (NCI-H187, MCF-7, and KB) as well as nonmalignant Vero cells with IC50values of 1.1-7.5 μg/mL, and these compounds also showed antimalarial activity with respective IC50of 3.1 and 2.8 μg/mL. © 2009 Elsevier Ltd. All rights reserved.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleCytotoxic eremophilane sesquiterpenoids from the saprobic fungus Berkleasmium nigroapicale BCC 8220en_US
dc.typeJournalen_US
article.title.sourcetitleTetrahedronen_US
article.volume65en_US
article.stream.affiliationsThailand National Center for Genetic Engineering and Biotechnologyen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.